BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29784573)

  • 1. PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia.
    Paquette M; Dufour R; Baass A
    J Clin Lipidol; 2018; 12(4):966-971. PubMed ID: 29784573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia.
    Paquette M; Dufour R; Baass A
    Can J Cardiol; 2017 Oct; 33(10):1312-1318. PubMed ID: 28941610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of polymorphism in PHACTR1 rs9349379 and rs12526453 with coronary artery atherosclerosis or coronary artery calcification. A systematic review.
    Koitsopoulos PG; Rabkin SW
    Coron Artery Dis; 2021 Aug; 32(5):448-458. PubMed ID: 33660664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHACTR1 gene polymorphism with the risk of coronary artery disease in Chinese Han population.
    Chen L; Qian H; Luo Z; Li D; Xu H; Chen J; He P; Zhou X; Zhang T; Chen J; Min X
    Postgrad Med J; 2019 Feb; 95(1120):67-71. PubMed ID: 30777881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia.
    Paquette M; Bernard S; Thanassoulis G; Baass A
    J Clin Lipidol; 2019; 13(4):627-633.e1. PubMed ID: 31103339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia.
    Miramontes-González JP; Usategui-Martín R; Pérez de Isla L; Alonso R; Muñiz-Grijalvo O; Díaz-Díaz JL; Zambón D; Jiménez FF; Martín-Vallejo J; Rodríguez Gude AE; Jiménez DL; Padro T; González-Sarmiento R; Mata P
    Atherosclerosis; 2019 Jun; 285():17-22. PubMed ID: 30991288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHACTR1 and SLC22A3 gene polymorphisms are associated with reduced coronary artery disease risk in the male Chinese Han population.
    Zhao Q; Wei H; Liu D; Shi B; Li L; Yan M; Zhang X; Wang F; Ouyang Y
    Oncotarget; 2017 Jan; 8(1):658-663. PubMed ID: 27893421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHACTR1 Gene Polymorphism Is Associated with Increased Risk of Developing Premature Coronary Artery Disease in Mexican Population.
    Pérez-Hernández N; Vargas-Alarcón G; Posadas-Sánchez R; Martínez-Rodríguez N; Tovilla-Zárate CA; Rodríguez-Cortés AA; Pérez-Méndez O; Blachman-Braun R; Rodríguez-Pérez JM
    Int J Environ Res Public Health; 2016 Aug; 13(8):. PubMed ID: 27517945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation.
    Ferrières J; Lambert J; Lussier-Cacan S; Davignon J
    Circulation; 1995 Aug; 92(3):290-5. PubMed ID: 7634440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia.
    Nomura A; Sato T; Tada H; Kannon T; Hosomichi K; Tsujiguchi H; Nakamura H; Takamura M; Tajima A; Kawashiri MA
    J Hum Genet; 2021 Nov; 66(11):1079-1087. PubMed ID: 33967275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians.
    Gaudet D; Vohl MC; Julien P; Tremblay G; Perron P; Gagné C; Bergeron J; Moorjani S; Després JP
    Am J Cardiol; 1998 Aug; 82(3):299-305. PubMed ID: 9708657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum homocysteine, methylenetetrahydrofolate reductase gene polymorphism and cardiovascular disease in heterozygous familial hypercholesterolemia.
    Pisciotta L; Cortese C; Gnasso A; Liberatoscioli L; Pastore A; Mannucci L; Irace C; Federici G; Bertolini S
    Atherosclerosis; 2005 Apr; 179(2):333-8. PubMed ID: 15777550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Li S; Wu NQ; Zhu CG; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Sun J; Liu G; Dong Q; Li JJ
    Atherosclerosis; 2017 May; 260():67-74. PubMed ID: 28351002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men.
    Gaudet D; Vohl MC; Couture P; Moorjani S; Tremblay G; Perron P; Gagné C; Després JP
    Atherosclerosis; 1999 Mar; 143(1):153-61. PubMed ID: 10208490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of polymorphism rs7041 and rs4588 of Vitamin D Binding Protein on the extent of coronary artery disease.
    Daffara V; Verdoia M; Rolla R; Nardin M; Marino P; Bellomo G; Carriero A; De Luca G;
    Nutr Metab Cardiovasc Dis; 2017 Sep; 27(9):775-783. PubMed ID: 28779988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients.
    Leus FR; Zwart M; Kastelein JJ; Voorbij HA
    Atherosclerosis; 2001 Feb; 154(3):641-9. PubMed ID: 11257265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANKS1A genotype predicts cardiovascular events in patients with familial hypercholesterolemia.
    Fantino M; Paquette M; Bernard S; Baass A
    J Clin Lipidol; 2021; 15(4):602-607. PubMed ID: 34130940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.